|
⚲
|
| Keyboard |
| Broadfin Capital LLC
✚
|
|
|---|---|
| CRD # | 156900 |
| SEC # | 801-73567 |
| CIK # | 0001511901 |
| AUM | |
| Employees | 9 (56% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-808-2460 |
| Address | 300 Park Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/19/2020) [Brochure] |
|---|
ITEM 5: FEES AND COMPENSATION Compensation for Advisory Services. The Investment Manager receives a quarterly management fee calculated at the annual rate of 2.0% of the net assets of each investor of the Domestic Feeder Fund and the Offshore Feeder Fund (the “Management Fee”). The Management Fee is paid quarterly in advance, based on the value of each Investor’s account value as of the beginning of each quarter. The Management Fee is prorated for any period that is less than a full quarter and is adjusted for contributions and withdrawals made during the quarter. In addition to management fees, Broadfin’s affiliate, Broadfin Advisors, LLC is entitled to receive performance based compensation ranging from 17.5% to 20% of the net profits, including realized and unrealized gains and losses, if any, of Investors of the Domestic Feeder Fund and the Offshore Feeder Fund, subject to a loss carryforward. The Management Fee and performance allocations are described in further detail in the offering documents for the Domestic Feeder Fund and Offshore Feeder Fund. Other Types of Expenses. Expenses absorbed by the Investment Manager include but are not limited to: utilities, furniture and fixtures, stationery, secretarial/internal administrative services, salaries, entertainment expenses, employee insurance, and payroll taxes. Fees, costs, and expenses, paid by the Funds include, but are not limited to: (1) the Management Fee; (2) performance allocations; (3) Fund legal, compliance, audit, tax, accounting, portfolio management/order management system costs, and administrator fees and expenses (including third party accounting services); (4) fees of outside consultants, analysts or advisors Broadfin may engage to provide advice related to portfolio investments; (5) brokerage commissions and securities transaction costs; (6) custodial, transfer agent and distributions agent charges; (7) expenses relating to insurance (including directors’ and officers’ insurance, errors and omission insurance, Fund indemnification coverage and other similar policies); (8) taxes and other governmental charges, fees and duties; (9) organizational expenses; (10) shareholder proxy voting services; (11) investment expenses such as research fees and expenses (including research-related travel, food and lodging); (12) interest on margin accounts and other indebtedness; (13) borrowing charges and dividend expenses on securities sold short; (14) director’s fees and expenses; and (15) any other fees, costs, expenses, and liabilities that are incurred by, or arise out of, the operation and activities of the Funds or the purchase, sale or transmittal of Fund assets. Each Feeder Fund will invest in the Master Fund on substantially the same terms and conditions and therefore will generally be allocated a proportionate share of the Master Fund’s gains, losses and expenses based on their interest in the Master Fund. The Master Fund will incur brokerage fees. Please see Item 12 of this brochure for further discussion of Broadfin’s brokerage practices. Broadfin Capital, LLC – ADV Part 2A 5 |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/19/2020) [Brochure] |
|---|
ITEM 7: TYPES OF CLIENTS The Firm’s only clients are the Feeder Funds and the Master Fund, which are private investment vehicles. Investors in the Funds may include individuals, investment companies, pooled investment vehicles, pension and profit sharing plans, trusts, estates, governmental plans, endowments, foundations, charitable organizations, corporations, insurance companies, limited partnerships, commingled investment trusts, and other entities. Investors in the Funds must generally be “accredited investors” as that term is defined in Rule 501 of Regulation D of the Securities Act of 1933 and “qualified purchasers” within the meaning of Section 2(a)(51) and Rule 2a51-1 under the Investment Company Act of 1940. Investors are required to commit or contribute certain minimum capital amounts to become Investors of the Domestic Feeder Fund and Offshore Feeder Fund. Currently, the minimum required investment is $1,000,000. This minimum amount is subject to change at the sole direction of the general partner for the Domestic Feeder Fund and Board of Directors for the Offshore Feeder Fund. Broadfin Capital, LLC – ADV Part 2A 7 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Biohaven Ltd | 0.1 | ||
| Alkermes PLC | 0.0 | ||
| Amarin Corp PLC UK | 0.0 | ||
| Staar Surgical Co | 0.0 | ||
| Genesis Biopharma Inc | 0.0 | ||
| Journey Medical Corp | 0.0 | ||
| Lantheus Holdings Inc | 0.0 | ||
| Aastrom Biosciences Inc | 0.0 | ||
| Sol-Gel Technologies Ltd | 0.0 | ||
| Camp Nine Inc | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Broadfin Healthcare Master Fund Ltd | 2012-02-14 | 739.5 M |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 739.5 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 739.5 |
| By Discretionary | ||
| Discretionary | 3 | 739.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 739.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 200.3 | |
| United States Persons | 539.3 | |
| Total | 3 | 739.5 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001511901] | |
| 3 | [0001511901] | |
| 4 | [0001511901] | |
| SC 13D | [0001511901] | |
| SC 13G | [0001511901] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 5493004SOHPILFJ75467 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biodelivery Sciences International Inc BDSI
Stock Options (right to buy) · derivative
|
2022-03-22 | Disposed to issuer | 7,500 | $0.00 | |
|
Biodelivery Sciences International Inc BDSI
Stock Options (right to buy) · derivative
|
2022-03-22 | Disposed to issuer | 85,760 | $0.00 | |
|
Biodelivery Sciences International Inc BDSI
Restricted Stock Units · derivative
|
2022-03-22 | Disposed to issuer | 22,685 | $0.00 | |
|
Biodelivery Sciences International Inc BDSI
Common Stock
|
2022-03-22 | Other | 7,588,395 | $0.00 | |
|
Biodelivery Sciences International Inc BDSI
Common Stock
|
2022-02-11 | Conversion | 2,422,222 | $1.80 | 4,360,000 |
|
Biodelivery Sciences International Inc BDSI
Series B Convertible Preferred Stock · derivative
|
2022-02-11 | Conversion | 436 | $10,000.00 | 4,360,000 |
|
Biodelivery Sciences International Inc BDSI
Restricted Stock Units · derivative
|
2022-01-27 | Grant | 15,369 | $0.00 | |
|
Biodelivery Sciences International Inc BDSI
Stock Options (right to buy) · derivative
|
2022-01-27 | Grant | 85,760 | $0.00 | |
|
Biodelivery Sciences International Inc BDSI
Restricted Stock Units · derivative
|
2022-01-27 | Option exercise | 7,684 | $0.00 | |
|
Biodelivery Sciences International Inc BDSI
Common Stock
|
2022-01-27 | Option exercise | 7,684 | $0.00 | |
|
Biodelivery Sciences International Inc BDSI
Common Stock
|
2021-11-19 | Buy | 100,000 | $3.06 | 306,000 |
|
Biodelivery Sciences International Inc BDSI
Common Stock
|
2021-11-12 | Buy | 100,000 | $3.20 | 320,000 |
|
Biodelivery Sciences International Inc BDSI
Common Stock
|
2021-11-05 | Buy | 257,800 | $3.47 | 894,566 |
|
Biodelivery Sciences International Inc BDSI
Stock Options (right to buy) · derivative
|
2021-08-10 | Conversion | 15,000 | $2.93 | 43,950 |
|
Biodelivery Sciences International Inc BDSI
Common Stock
|
2021-08-10 | Option exercise | 15,000 | $2.93 | 43,950 |
|
Biodelivery Sciences International Inc BDSI
Common Stock
|
2021-08-06 | Option exercise | 30,000 | $0.00 | |
|
Biodelivery Sciences International Inc BDSI
Restricted Stock Units · derivative
|
2021-08-06 | Option exercise | 30,000 | $0.00 | |
|
Biodelivery Sciences International Inc BDSI
Common Stock
|
2021-05-13 | Buy | 50,000 | $3.25 | 162,500 |
|
Biodelivery Sciences International Inc BDSI
Common Stock
|
2021-05-12 | Buy | 100,000 | $3.24 | 324,000 |
|
Biodelivery Sciences International Inc BDSI
Common Stock
|
2021-05-11 | Buy | 150,000 | $3.16 | 474,000 |
| showing 20 of 178 most recent transactions | |||||